New COVID Variant XFG: What Makes Stratus Different, and What to Expect

XFG 'American COVID' Variant: What Australians Need to Know About Stratus in 2026

, by Tatianna Gerard , 16 min reading time

Last updated: November 2026. This article was first published in July 2025 and has been updated with the latest information.

If you've seen headlines about a COVID strain called "American COVID" lately, you might be wondering whether there's a brand-new variant to worry about.

In fact, it's not new at all. The variant behind those headlines is XFG, informally known as Stratus. We first wrote about it back in July 2025, when it had just been added to the World Health Organization's watch list.

You might also remember our article on NB.1.8.1, the variant nicknamed Nimbus. And no, the WHO isn't pulling inspiration from Harry Potter. Nimbus and stratus are both types of clouds, not broomsticks, which does make tracking COVID strains feel oddly atmospheric.

Since then, XFG has gone from a newcomer to the most common COVID-19 variant worldwide. But here's the reassuring part: there's still no evidence it causes more severe illness than other variants, and vaccines continue to offer protection, especially against serious disease.

What is "American COVID"?

"American COVID" isn't an official name. It's a nickname that's been used in some media coverage, particularly in the UK, for the XFG (Stratus) variant. Scientists and health authorities still refer to it as XFG.

So why "American"? There isn't one clear answer:

Here's the irony: XFG has since been overtaken in the US by newer variants, including some of its own descendants. So "American COVID" isn't actually the leading strain in America anymore.

The most important thing to know is that the nickname doesn't mean it's a new or more dangerous strain. It's simply back in the spotlight because COVID activity has picked up in parts of the Northern Hemisphere.

What is the XFG (Stratus) variant?

XFG is a subvariant of Omicron, the branch of the COVID-19 virus that has caused almost all infections since 2022. It was first detected in January 2025, and the WHO designated it a Variant Under Monitoring (VUM) on 25 June 2025.

What makes XFG a little different is that it's a recombinant. That means it's a blend of two existing COVID-19 strains, in this case LF.7 and LP.8.1.2.

Image via @TRyanGregory
(Source: https://x.com/username/status/1234567890)

Recombinant variants happen when two different strains infect the same person and swap genetic material, creating a new version with features of both. This isn't unusual, and it doesn't automatically make a variant more dangerous. But it does mean scientists keep a closer eye on it.

XFG carries several changes in its spike protein that help it get around antibodies from past infections or vaccination. That's likely part of the reason it has spread so widely. Interestingly, it also binds less strongly to the receptor the virus uses to enter our cells.

Most importantly, there's still no evidence that XFG leads to more severe illness than other COVID-19 variants in circulation.

Where is XFG now?

Around the world

XFG has come a long way since we first covered it. By June 2025, it already made up around 17% of sequenced samples in Europe, more than a quarter in the Americas and as many as 69% in South-East Asia.

Today, it's the most common COVID-19 variant globally. According to the WHO, XFG accounted for 52% of all submitted sequences in the week ending 4 October 2026, up from 44% a month earlier. In Europe, health authorities list XFG as the dominant variant across the EU.

In Australia

Australia's picture is a little different. Here, XFG is circulating, but it isn't the leading variant. According to the latest Australian Respiratory Surveillance Report, in the 28 days to 4 October 2026:

  • NB.1.8.1 (Nimbus) was the most common variant, making up 44.6% of sequences
  • PQ.16.1.1 made up 18 sequences
  • XFG (Stratus) made up 10 sequences
  • BA.3.2 (Cicada) made up 8.4% of sequences

It's worth keeping in mind that only a small number of samples are being sequenced in Australia right now (83 in that period), so these figures give a general picture rather than a precise one.

In short: XFG is the most common overseas, but in Australia, NB.1.8.1 is still the leading variant for now. Health authorities continue to monitor how these variants change over time.

Symptoms — Is XFG different from other variants?

For most people, XFG causes the same mix of respiratory and cold-like symptoms seen with other recent Omicron strains, including:

  • Sore throat
  • Fatigue
  • Headache
  • Nasal congestion or runny nose
  • Cough
  • Muscle aches
  • Fever (in some cases)

What about the "raspy voice"?

When XFG first appeared, doctors in India reported that a hoarse or raspy voice seemed to be showing up more often. That observation has stuck, and you'll still see it mentioned in a lot of "American COVID" headlines.

However, the evidence since then is more mixed. A large study from the Netherlands, which compared people infected with XFG to those infected with an earlier variant, found XFG wasn't linked to higher rates of sore throat or more severe illness. (This study is a preprint, so it hasn't yet been peer reviewed.)

The takeaway: a hoarse voice can happen with COVID, but it's not a reliable way to tell whether you have XFG, another COVID variant, or a different bug altogether. Many respiratory infections share similar symptoms.

If you're feeling unwell, it's best to test to find out what you've got, rest, and stay away from vulnerable people while you recover. If your symptoms are severe or you're at higher risk, speak to your GP.

Are current COVID vaccines still effective?

The short answer is yes. Here's where things stand.

What the evidence says

Laboratory studies suggest COVID-19 vaccines continue to generate immune responses against XFG, even those designed around earlier Omicron strains.

In May 2026, the WHO's expert group on vaccine composition recommended that manufacturers continue using LP.8.1 as the basis for updated COVID-19 vaccines. They noted these vaccines boost antibodies that can neutralise XFG, NB.1.8.1 and other circulating variants. Vaccines based on XFG or NB.1.8.1 could also be used.

What's available in Australia

In Australia, the main COVID-19 vaccine now in use is Comirnaty LP.8.1, made by Pfizer. A Moderna LP.8.1 vaccine has also been registered here.

You may have read that Pfizer has a newer vaccine designed specifically for XFG. That's true. It's been approved in the United States for the 2026–27 season, but isn't yet registered in Australia. Experts say this doesn't mean the vaccines available here don't work. It's more about how quickly the newest versions reach the Australian market.

The bottom line on vaccines

COVID-19 vaccines don't reliably stop you catching the virus, but they remain one of our best defences against severe disease and hospitalisation. The WHO also advises that people at highest risk shouldn't delay vaccination while waiting for a newer formula.

Who can get a free COVID vaccine in Australia now?

There's been an important change you may have missed. From 1 October 2026, COVID-19 vaccines moved to the National Immunisation Program (NIP), replacing the separate COVID-19 vaccine program set up during the pandemic.

Under the new arrangements, free COVID-19 vaccines are available for:

Who

Free doses per year

Adults aged 75 and over

2

Adults aged 65–74

1

Aboriginal and Torres Strait Islander adults aged 50–74

1

Adults aged 18–64 with severe immunocompromise

1

 

Where two doses a year are recommended, they're given about six months apart.

Not on the list? If you're not eligible for a free dose, you can still choose to buy a COVID-19 vaccine privately after talking through the risks and benefits with your doctor or pharmacist. Pregnant women can also consider a dose from 20 weeks of pregnancy.

Your GP or local pharmacist can tell you which recommendations apply to you.

What about BA.3.2, the "Cicada" variant?

XFG isn't the only variant with a nickname. You may also have heard of BA.3.2, sometimes called "Cicada".

BA.3.2 is a highly divergent descendant of the older Omicron BA.3 lineage, first detected in South Africa in late 2024. The WHO designated it a Variant Under Monitoring in December 2025.

What makes BA.3.2 interesting is that it's genetically quite different from the JN.1 family that XFG and NB.1.8.1 belong to. That gives it a greater ability to dodge existing immunity. However, it hasn't shown the same ability to outcompete faster-spreading variants like XFG and NB.1.8.1 in most places.

In Australia, BA.3.2 has been showing up steadily in sequencing data, making up 8.4% of sequences in the most recent reporting period.

The WHO currently assesses the public health risk of BA.3.2 as low, with no evidence of more severe illness, hospitalisation or death, although the evidence is still limited.

And PQ.16.1.1?

PQ.16.1.1 is another variant now on the WHO's monitoring list, and it's been appearing in Australian sequencing too. Like the others, the WHO says it doesn't currently pose additional public health risks compared with other circulating variants.

What is a Variant Under Monitoring (VUM)?

You'll often see the term "Variant Under Monitoring" (VUM) in reports about XFG and BA.3.2. But what does it actually mean?

The WHO uses a three-tier system to flag COVID-19 variants worth watching:

  1. Variant Under Monitoring (VUM): The lowest level. The variant has genetic changes that might affect how it spreads or how it interacts with our immune system, but there isn't yet enough evidence that it poses extra risk. Essentially it means: "This one could matter, so let's keep an eye on it."
  2. Variant of Interest (VOI): A variant with clearer signs that it may spread more easily or dodge immunity.
  3. Variant of Concern (VOC): The highest level, for variants that clearly affect spread, severity or how well vaccines and treatments work.

So when XFG is described as a VUM, it simply means scientists are watching it closely. It's not a cause for alarm on its own.

COVID-19 variants currently tracked by the WHO

As of November 2026, these are the variants on the WHO's watch list:

Variant

Nickname

Category

What it is

JN.1

Juno

Variant of Interest

Omicron sublineage and the parent of most current variants

XFG

Stratus / "American COVID"

Variant Under Monitoring

Recombinant of LF.7 and LP.8.1.2

NB.1.8.1

Nimbus

Variant Under Monitoring

Descendant of JN.1

PQ.16.1.1

—

Variant Under Monitoring

Omicron sublineage

BA.3.2

Cicada

Variant Under Monitoring

Descendant of Omicron BA.3

 

Note: Variant classifications change as new data emerge. For the most up-to-date list, check the WHO COVID-19 variant dashboard.

Conclusion

"American COVID" isn't a new threat. It's XFG (Stratus), a variant that's been around since early 2025 and has become the most common strain worldwide. There's still no evidence it causes more severe illness, and current vaccines continue to offer protection against serious disease.

Here in Australia, NB.1.8.1 remains the leading variant for now, with XFG, BA.3.2 and PQ.16.1.1 also circulating. Health authorities are keeping a close eye on all of them.

The best things you can do haven't changed:

  • Check whether you're due for a COVID-19 vaccine, especially if you're 65 or over or have a health condition.
  • Test if you feel unwell, and stay home if you can when you're sick.
  • Keep up good hygiene, like regular hand washing and covering coughs and sneezes.
  • Consider a mask in crowded indoor spaces or when travelling, particularly to places where COVID is rising.

And if your voice sounds a little hoarse this week? It might just be a cold, but a quick test can give you peace of mind. The Sonictec 5-in-1 Combo Rapid Antigen Test checks for COVID-19, influenza A & B, RSV and adenovirus in one simple test, so you can get clarity on your symptoms quickly, whether you're at home, at work or about to travel.

This article is for general information only and isn't a substitute for advice from your doctor or other health professional.

Test, Protect, Clean: All Your Essentials in One Place

Sonictec 5-in-1 Rapid Antigen Test

Sonictec 5-in-1 Rapid Antigen Test (ADV, RSV, Flu A/B & Covid-19)

From $9.85

Buy Now
AMD Australian-Made P2 Respirator Mask

AMD Australian-Made P2 Respirator Mask

From $29.95

Buy Now
ViroCLEAR Alcohol-Free Hand Sanitiser

ViroCLEAR Alcohol-Free Hand Sanitiser

From $4.50

Buy Now
Dettol Antiseptic Liquid - Household-Grade Disinfectant - 500mL

Dettol Antiseptic Liquid - Household-Grade Disinfectant - 500mL

From $9.90

Buy Now
ViroCLEAR Fogger

ViroCLEAR Sanitiser & Protectant Disinfectant Fogger

From $8.50

Buy Now
Clinell Universal Wipes Clip Pack

Clinell Universal Wipes – Clip Pack (50 Wipes)

From $9.98

Buy Now

Tags

© 2026 Aussie Pharma Direct, Powered by Shopify

    • American Express
    • Apple Pay
    • Bizum
    • Google Pay
    • Mastercard
    • PayPal
    • Satispay
    • Shop Pay
    • Union Pay
    • Visa
    • WeChat Pay

    Login

    Forgot your password?

    Don't have an account yet?
    Create account